ESYT2 Antibody, FITC conjugated

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
We typically dispatch orders within 1-3 business days of receipt. Delivery times may vary depending on the method of purchase and the delivery location. Please consult your local distributor for specific delivery details.
Synonyms
ESYT2 antibody; FAM62B antibody; KIAA1228Extended synaptotagmin-2 antibody; E-Syt2 antibody; Chr2Syt antibody
Target Names
ESYT2
Uniprot No.

Target Background

Function
ESYT2 antibody plays a crucial role in cellular processes by tethering the endoplasmic reticulum to the cell membrane and facilitating the formation of appositions between these two structures. This protein binds to glycerophospholipids within a barrel-like domain, potentially contributing to cellular lipid transport. Furthermore, ESYT2 participates in FGF signaling by mediating the rapid internalization of activated FGFR1 following FGF1 binding. This internalization likely occurs via the AP-2 complex. ESYT2 also promotes the localization of SACM1L at endoplasmic reticulum-plasma membrane contact sites (EPCS).
Gene References Into Functions
  1. ESyt2 and ESyt3, but not ESyt1, interact with activated FGFR1. PMID: 25922075
  2. The crystal structure of a fragment of extended synaptotagmin 2, resolved at 2.44 A resolution, reveals an SMP domain and two adjacent C2 domains. This structure provides evidence for the role of SMP-domain-containing proteins in regulating lipid transfer at membrane contact sites. PMID: 24847877
  3. Extended synaptotagmins (E-Syt1, E-Syt2, and E-Syt3) are endoplasmic reticulum-anchored proteins that form homo- and heteromeric complexes. These complexes mediate contacts with the plasma membrane. These contacts are critically dependent on the presence of PI(4,5)P2 in the plasma membrane and are further regulated by cytosolic Ca2+ via the Ca2+-sensing property of E-Syt1. PMID: 23791178
Database Links

HGNC: 22211

KEGG: hsa:57488

STRING: 9606.ENSP00000251527

UniGene: Hs.490795

Protein Families
Extended synaptotagmin family
Subcellular Location
Cell membrane; Peripheral membrane protein. Endoplasmic reticulum membrane; Multi-pass membrane protein.
Tissue Specificity
Widely expressed with high level in cerebellum.

Q&A

What is ESYT2 and why is it significant in cellular research?

ESYT2, also known as FAM62B, is an extended synaptotagmin-like protein that plays a critical role in membrane contact sites between the endoplasmic reticulum (ER) and plasma membrane (PM). These ER-PM contact sites are essential for various cellular processes including lipid transfer, calcium signaling, and cell adhesion. Research has implicated ESYT2 in extracellular signal transduction and cell adhesion functions . The protein is encoded on chromosome 12 and is part of a family of proteins that includes ESYT1 and ESYT3, which have tissue-specific expression patterns . ESYT2's membrane localization makes it particularly valuable for studying ER-PM interactions in different cell types and under various physiological conditions.

What are the technical specifications of ESYT2/FAM62B Polyclonal Antibody with FITC conjugation?

The ESYT2/FAM62B Polyclonal Antibody with FITC conjugation is typically derived from rabbit hosts using KLH-conjugated synthetic peptides from human ESYT2/FAM62B protein (immunogen range: 801-921/921) . The antibody has the following specifications:

SpecificationDetails
HostRabbit
ClonalityPolyclonal
IsotypeIgG
ConjugationFITC (Fluorescein Isothiocyanate)
Concentration1ug/ul
Purification MethodProtein A
Storage BufferAqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol
Storage ConditionStore at -20°C with aliquoting recommended to avoid freeze-thaw cycles
Predicted ReactivityHuman, Mouse, Rat, Cow, Sheep, Pig, Horse, Chicken

How does FITC conjugation impact antibody functionality and application?

  • FITC-conjugated antibodies are sensitive to light exposure, which gradually diminishes fluorescence intensity .

  • The conjugation process may slightly affect the antibody's binding affinity compared to unconjugated versions.

  • FITC has an excitation maximum at approximately 495 nm and emission maximum at approximately 520 nm, requiring appropriate filter sets for visualization.

  • Direct conjugation eliminates potential cross-reactivity issues associated with secondary antibodies, particularly important in multi-labeling experiments.

What are the validated applications for ESYT2 Antibody, FITC conjugated?

The ESYT2/FAM62B polyclonal antibody with FITC conjugation has been validated for multiple experimental applications :

  • Western Blotting (WB) - For detecting ESYT2 protein in cell and tissue lysates

  • Immunofluorescence on paraffin-embedded tissues (IF/IHC-P) - For localizing ESYT2 in fixed tissue sections

  • Immunofluorescence on frozen tissue sections (IF/IHC-F) - For detecting ESYT2 in cryopreserved samples

  • Immunocytochemistry (ICC) - For visualizing ESYT2 localization in cultured cells

These applications leverage the antibody's specificity for ESYT2/FAM62B and the direct visualization capabilities provided by the FITC conjugation.

What is the recommended protocol for immunofluorescence using FITC-conjugated ESYT2 antibody?

For optimal results with immunofluorescence using FITC-conjugated ESYT2 antibody, follow this methodological approach based on standard protocols for FITC-conjugated antibodies :

  • Sample Preparation:

    • Seed cells on appropriate coverslips or glass-bottomed plates

    • For tissue sections, prepare paraffin-embedded or frozen sections as needed

  • Fixation and Permeabilization:

    • Fix cells using 4% paraformaldehyde in PBS for 10 minutes at room temperature

    • Wash thoroughly with PBS

    • Permeabilize with 0.1% Triton X-100 for 10 minutes

    • Wash again with PBS

  • Blocking:

    • Incubate with blocking buffer (10% FBS, 1% BSA, 0.1% Triton X-100, and 0.01% NaN₃ in PBS) for 1 hour at room temperature

  • Antibody Incubation:

    • Dilute the FITC-conjugated ESYT2 antibody (recommended starting dilution 1:500) in blocking buffer

    • Incubate overnight at 4°C in a humidity chamber protected from light

    • Wash thoroughly with PBS (3-5 times, 5 minutes each)

  • Counterstaining (optional):

    • Counterstain nuclei with DAPI if desired

    • For multi-labeling experiments, use antibodies with compatible fluorophores

  • Mounting and Imaging:

    • Mount with appropriate anti-fade mounting medium

    • Image using fluorescence microscopy with appropriate FITC filter sets

    • For optimal results in membrane contact site studies, consider using total internal reflection fluorescence (TIRF) microscopy

How should researchers optimize FITC-conjugated ESYT2 antibody dilutions for different experimental applications?

Optimizing antibody dilution is crucial for balancing specific signal and background. For FITC-conjugated ESYT2 antibody:

  • Initial Titration Series:

    • For immunofluorescence: Start with 1:500 dilution as recommended, then test 1:250, 1:500, 1:1000, and 1:2000

    • For Western blotting: Begin with 1:1000 dilution as referenced for non-conjugated ESYT2 antibody , then test 1:500 and 1:2000

  • Sample-Specific Considerations:

    • Cell lines with high ESYT2 expression (e.g., lung, spleen, testis, stomach tissues) may require higher dilutions

    • Primary cells versus cell lines may require different optimal dilutions

    • Fixed versus live cell applications may have different requirements

  • Application-Specific Optimization:

    • Western blotting may require different dilutions than immunofluorescence

    • TIRF microscopy focusing on membrane contacts may benefit from higher antibody concentrations than wide-field imaging

    • Always include positive and negative controls when optimizing dilutions

How do endoplasmic reticulum-plasma membrane (ER-PM) contact sites impact ESYT2 localization and experimental design?

ESYT2 is involved in establishing and maintaining ER-PM contact sites, which has significant implications for experimental design :

  • Membrane Contact Site Gradients:

    • Recent research has demonstrated that ER-PM contacts form gradients within cells

    • These gradients appear to direct key cellular processes

    • When studying ESYT2, researchers should consider its distribution across these gradients rather than simple presence/absence in subcellular fractions

  • Visualization Techniques:

    • Total internal reflection fluorescence (TIRF) microscopy is particularly valuable for visualizing ESYT2 at ER-PM contact sites

    • This technique captures signals from the evanescent field, which extends only 100-200 nm from the coverslip surface

    • Using TIRF with FITC-conjugated ESYT2 antibody enables high-contrast imaging of membrane contact sites

  • Co-localization Studies:

    • Consider co-staining with ER markers (e.g., SEC61β) and PM markers (e.g., CAAX-tagged fluorophores)

    • For advanced studies, cryo-electron tomography (cryo-ET) can provide nanometer-resolution of contact sites

How does tissue-specific expression of ESYT2 influence experimental design and interpretation?

ESYT2 expression varies significantly across tissues, which has important implications for experimental design :

  • Tissue Expression Profile:

    • ESYT2 mRNA is predominantly detected in lung, spleen, testis, and stomach

    • Lower expression levels are found in other tissues

    • This expression pattern overlaps significantly with ESYT1, except in testis

  • Experimental Implications:

    • Cell line selection should account for natural ESYT2 expression levels

    • RPE-1, HUVEC/TERT2, and BJ-5ta cells have been successfully used for studying ESYT2

    • When studying ESYT2 in tissues or cell types with low endogenous expression, sensitivity limitations must be considered

  • Knockout Studies Interpretation:

    • Research has shown that loss of ESYT2 (and ESYT3) does not affect mouse viability

    • Genetic compensation or functional redundancy with ESYT1 may mask phenotypes

    • When designing knockout or knockdown experiments, consider potential compensatory mechanisms

What controls should be included when using FITC-conjugated ESYT2 antibody in advanced research applications?

For rigorous scientific validation, include these controls when working with FITC-conjugated ESYT2 antibody:

  • Positive Controls:

    • Tissues known to express high ESYT2 levels (lung, spleen, testis, stomach)

    • Cell lines with confirmed ESYT2 expression

    • Overexpression systems with tagged ESYT2 constructs

  • Negative Controls:

    • ESYT2 knockout or knockdown samples

    • Isotype control antibodies (rabbit IgG-FITC) to assess non-specific binding

    • Secondary antibody-only controls (for comparison with non-conjugated primary antibodies)

  • Specificity Controls:

    • Pre-absorption with immunizing peptide to confirm binding specificity

    • Western blot validation to confirm molecular weight of detected protein

    • Multiple antibodies targeting different epitopes of ESYT2 to confirm localization patterns

How can researchers address photobleaching issues with FITC-conjugated antibodies?

FITC is particularly susceptible to photobleaching, which can limit experimental duration and quantitative analysis . To address this:

  • Preventative Measures:

    • Minimize light exposure during all sample preparation steps

    • Use anti-fade mounting media containing anti-photobleaching agents

    • Store slides and samples in the dark at 4°C

    • Consider working under reduced ambient lighting conditions

  • Imaging Strategies:

    • Use neutral density filters to reduce excitation intensity

    • Minimize exposure times and interval durations for time-lapse imaging

    • Capture FITC channel images first in multi-channel acquisition sequences

    • Consider deconvolution strategies to enhance signal from lower exposure images

  • Alternative Approaches:

    • For long-term imaging or quantitative applications, consider antibodies conjugated to more photostable fluorophores (Alexa Fluor 488)

    • For fixed samples requiring archiving, document images promptly after preparation

What are potential causes and solutions for high background when using FITC-conjugated ESYT2 antibody?

High background can compromise signal-to-noise ratio in immunofluorescence experiments. Common causes and solutions include:

  • Inadequate Blocking:

    • Extend blocking time to 2 hours or overnight at 4°C

    • Increase blocking agent concentration (try 15-20% FBS or 2-5% BSA)

    • Add 0.1-0.3M glycine to blocking buffer to reduce aldehyde-induced autofluorescence

  • Non-specific Binding:

    • Increase antibody dilution (try 1:1000 or 1:2000)

    • Add 0.1-0.5% non-ionic detergent (Tween-20) to washing buffers

    • Pre-absorb antibody with acetone powder from non-target tissues

  • Autofluorescence:

    • Treat samples with 0.1-1% sodium borohydride after fixation to reduce autofluorescence

    • Include 10mM cupric sulfate in 50mM ammonium acetate (pH 5.0) treatment

    • Use spectral unmixing during image acquisition or processing

  • Fixation Issues:

    • Optimize fixation time (over-fixation can increase background)

    • Try alternative fixatives (methanol instead of paraformaldehyde)

    • Ensure complete permeabilization for intracellular epitopes

How should researchers interpret ESYT2 subcellular localization patterns?

ESYT2 localization requires careful interpretation based on its known roles at ER-PM contact sites :

  • Expected Localization Patterns:

    • Primarily at the cell membrane, particularly at ER-PM contact sites

    • Punctate distribution rather than continuous membrane staining

    • Potential co-localization with ER markers at membrane-proximal sites

    • May form gradients across the cell rather than uniform distribution

  • Interpretation Approaches:

    • Use co-localization with established markers (SEC61β for ER, CAAX for PM)

    • Compare distribution under normal conditions versus after calcium elevation (which may affect ESYT2 recruitment)

    • Consider three-dimensional distribution using z-stack imaging

    • Quantify intensity distributions relative to cell landmarks or gradients

  • Comparative Analysis:

    • Compare ESYT2 patterns with related proteins ESYT1 and ESYT3

    • Consider cell type-specific differences in localization patterns

    • Analyze changes in localization under different physiological or stress conditions

What quantitative methods are recommended for analyzing ESYT2 distribution at ER-PM contact sites?

For robust quantitative analysis of ESYT2 at ER-PM contact sites:

  • Contact Site Quantification:

    • Measure density of ESYT2-positive puncta per unit membrane length

    • Calculate percentage of cell periphery containing ESYT2-positive contacts

    • Measure intensity profiles perpendicular to the plasma membrane to assess depth of contacts

  • Gradient Analysis:

    • Develop line scan analyses across cellular axes to quantify ESYT2 distribution gradients

    • Use polar coordinate transformations to normalize cells of different shapes

    • Apply heat maps to visualize distributional differences across experimental conditions

  • Co-localization Analysis:

    • Calculate Pearson's or Manders' correlation coefficients with ER and PM markers

    • Use object-based colocalization to identify bona fide contact sites

    • Apply super-resolution techniques (STORM, STED) for nanometer-scale analysis

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.